4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate is a chemical compound used as a pharmaceutical intermediate. It is a salt hydrate form of a dichloropyridazine carboxylic acid derivative.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 2245111-15-1
Lithium 4,6-Dichloropyridazine-3-carboxylate
Pharmaceutical intermediate for deucravacitinib
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-
Pharmaceutical intermediate for deucravacitinib synthesis
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
Pharmaceutical intermediate for deucravacitinib
Zinc(II) 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylate
Zinc salt pharmaceutical intermediate
(2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone Phthalimido
Pharmaceutical impurity reference standard
4,6-dichloropyridazine-3-carboxylic acid
pharmaceutical intermediate
lithium;4,6-dichloropyridazine-3-carboxylate;hydrate
KOGSKEZOKTYPFE-UHFFFAOYSA-M
[Li+].C1=C(C(=NN=C1Cl)C(=O)[O-])Cl.O
—